BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 11807828)

  • 1. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H; King GL; Ferrara N; Aiello LP
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A; Dunk C; Kniss D; Wilkes M
    Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
    Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
    Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
    Frank S; Stallmeyer B; Kämpfer H; Schaffner C; Pfeilschifter J
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
    Bogic LV; Brace RA; Cheung CY
    Placenta; 2001 Apr; 22(4):265-75. PubMed ID: 11286562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells.
    Trachtman H; Futterweit S; Franki N; Singhal PC
    Biochem Biophys Res Commun; 1998 Apr; 245(2):443-6. PubMed ID: 9571172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF-induced permeability increase is mediated by caveolae.
    Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A; Mayr U; Frank H; Waltenberger J
    Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
    Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.
    Yang SP; Morita I; Murota SI
    J Cell Physiol; 1998 Aug; 176(2):342-9. PubMed ID: 9648921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.
    Feng Y; Venema VJ; Venema RC; Tsai N; Caldwell RB
    Biochem Biophys Res Commun; 1999 Mar; 256(1):192-7. PubMed ID: 10066445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells.
    Cha MS; Lee MJ; Je GH; Kwak JY
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1061-6. PubMed ID: 11352660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy.
    Nakagawa T; Sato W; Sautin YY; Glushakova O; Croker B; Atkinson MA; Tisher CC; Johnson RJ
    J Am Soc Nephrol; 2006 Mar; 17(3):736-45. PubMed ID: 16436494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.